주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요 새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Profile

Kanta Subbarao

KS

Kanta Subbarao

Université Laval, Canada

Professor Kanta Subbarao is a virologist and a paediatric infectious disease physician. She has worked on molecular virology and vaccine development for emerging viruses that pose a potential pandemic threat, including influenza viruses, SARS and MERS and SARS-CoV-2 coronaviruses. She holds a Canada Excellence Research Chair position on Biology and Control of Zoonotic and Pandemic Respiratory Viruses at Laval University in Quebec and is a professor in the Department of Microbiology and Immunology, The University of Melbourne. From 2016-2024 she was the Director of the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne, Australia and before that she was the Chief of the Emerging Respiratory Viruses Section of the Laboratory of Infectious Diseases, NIAID, NIH. She is an internationally recognized leader in the field of influenza and received the 2024 Lifetime Achievement award from the International Society for Influenza and Other Respiratory Viruses. She is a Fellow of the Australian Academy of Health and Medical Sciences, American Academy of Microbiology and the Infectious Diseases Society of America.